INTRODUCTION
The intestine is a unique tissue where a refined balance is maintained between immune responses and tolerance against a variety of environmental factors including microflora and food antigens. In the intestine, aberrant inflammatory responses can cause development of inflammatory bowel disease (IBD), which is characterized by two main clinical forms, Crohn's disease (CD) and ulcerative colitis (UC). Moreover, it was commonly assumed that intestinal inflammation was caused by a disruption in the balance between Th1 and Th2 cytokine responses. In addition, abnormal activation of Th17 cells has been implicated in the pathogenesis of CD. The number of Th1 cells and Th17 cells increased in the lamina propria of patients with IBD compared with healthy individuals, suggesting that a Th1/Th17 pathway may contribute to the development of IBD (1) .
At steady state, the number and activity of effector T cells are tightly regulated by gut homeostasis (4) . Treg cell-derived IL-10 is thought to regulate the activity of intestinal myeloid cells.
Recently, several innate immune subsets have been reported to modulate the intestinal homeostasis through regulation of adaptive immune responses in mouse (5-7). In the intestine, activity of innate immune myeloid cells such as dendritic cells and macrophages is finely regulated by several mechanisms because the excessive and inadequate initiation of innate immunity leads to the development of IBD. Accordingly, patients with CD possess inappropriate or defective innate immune functions, including cytokine production, pathogen clearance, and recruitment of neutrophils. Genome-wide mapping has identified the genes and genetic loci that contribute to IBD susceptibility, including IL-10, IL-12p40, IL-23R and CARD9 (8, 9) . Thus, intestinal innate immune cells are responsible for maintenance of the gut homeostasis, and dysregulation of activity of these cells lead to development of IBD through induction of colitogenic effector T cells. This review focuses on a variety of murine innate immune subsets, which are responsible for maintenance of the gut homeostasis leading to prevention of intestinal inflammation, and human intestinal myeloid cells implicated in pathogenesis of IBD.
REGULATION OF ADAPTIVE IMMUNITY BY THE INTESTINAL INNATE IMMUNE SUBSETS
The intestinal mononuclear phagocytes could be subdivided several subsets possessing different ability to maintain gut homeostasis either through promoting or preventing T cell responses (10-13), according to expression pattern of characteristic surface marker including CD11b, CD11c, CD103 and CX3CR1. In particular, CD103
＋ dendritic cells and CX3CR1 
CD11b
＋ dendritic cells in response to flagellin promotes epithelial expression of RegIIIγ through induction of IL-22 production by innate lymphoid cells (23) (Fig. 1B) 
REGULATION OF IBD BY HUMAN MYELOID SUBSETS

Human intestinal macrophage
Recent studies have suggested that the intestinal macrophages play important roles in protecting host from invading pathogens and regulating excess immune responses to commensal bacteria by producing IL-10 ( Fig. 3A) . Interestingly, numbers of CD14 ＋ macrophage are increased in patients with CD and produce greater amounts of colitogenic cytokines including IL-6, IL-23 and TNF-α against microbiota than do healthy individuals (38) . Furthermore, human intestinal CD14 ＋ macrophage-derived IL-23 may enhance colitogenic IL-17 and IFN-γ -producing T cell differentiation, suggesting that abnormal innate immune responses by macrophages play a major role in the pathogenesis of IBD (38-41) (Fig. 3B) . (Fig. 3A) , suggesting that these cells might be equivalent to murine CD103 
